• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth

    6/20/25 8:55:00 AM ET
    $AII
    $ICE
    $NVS
    Property-Casualty Insurers
    Finance
    Investment Bankers/Brokers/Service
    Finance
    Get the next $AII alert in real time by email

    NEW YORK, June 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Kristen Scholer delivers the pre-market update on June 20th

    • Traders return to Wall Street this morning following the Juneteenth Holiday for the final day of trading this week. Stocks are down fractionally early Friday and are little changed on the week.
    • Equities had a mixed session Wednesday after the Federal Reserve kept interest rates unchanged. Following the decision, Fed Chair Powell said the central bank is "well-positioned to wait" before lowering rates.
    • On Thursday, White House Press Secretary Karoline Leavitt said that President Trump will decide if the U.S. will get involved in the Middle East conflict over the next two weeks.

    Opening Bell

    ZERO Prostate Cancer & Novartis (NYSE:NVS) commemorate Men's Health Month

    Closing Bell

    American Integrity (NYSE:AII) celebrates the launch of its IPO

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--wall-street-reopens-after-juneteenth-302487077.html

    SOURCE New York Stock Exchange

    Get the next $AII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AII
    $ICE
    $NVS

    CompanyDatePrice TargetRatingAnalyst
    Novartis AG
    $NVS
    9/12/2025$118.00Neutral → Sell
    Goldman
    Novartis AG
    $NVS
    8/8/2025$123.00Underweight → Equal-Weight
    Morgan Stanley
    American Integrity Insurance Group Inc.
    $AII
    6/6/2025Outperform
    William Blair
    American Integrity Insurance Group Inc.
    $AII
    6/2/2025Perform
    Oppenheimer
    American Integrity Insurance Group Inc.
    $AII
    6/2/2025Outperform
    Keefe Bruyette
    American Integrity Insurance Group Inc.
    $AII
    6/2/2025$20.00Outperform
    Raymond James
    American Integrity Insurance Group Inc.
    $AII
    6/2/2025$20.00Overweight
    Piper Sandler
    American Integrity Insurance Group Inc.
    $AII
    6/2/2025$23.00Mkt Outperform
    Citizens JMP
    More analyst ratings

    $AII
    $ICE
    $NVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Novartis AG downgraded by Goldman with a new price target

    Goldman downgraded Novartis AG from Neutral to Sell and set a new price target of $118.00

    9/12/25 7:50:34 AM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Novartis AG upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Novartis AG from Underweight to Equal-Weight and set a new price target of $123.00

    8/8/25 7:57:50 AM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on American Integrity Insurance Group

    William Blair initiated coverage of American Integrity Insurance Group with a rating of Outperform

    6/6/25 8:34:22 AM ET
    $AII
    Property-Casualty Insurers
    Finance

    $AII
    $ICE
    $NVS
    SEC Filings

    View All

    SEC Form 6-K filed by Novartis AG

    6-K - NOVARTIS AG (0001114448) (Filer)

    9/30/25 5:12:33 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by American Integrity Insurance Group Inc.

    8-K - American Integrity Insurance Group, Inc. (0002007587) (Filer)

    9/23/25 4:05:15 PM ET
    $AII
    Property-Casualty Insurers
    Finance

    Intercontinental Exchange Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Intercontinental Exchange, Inc. (0001571949) (Filer)

    9/18/25 4:30:58 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $AII
    $ICE
    $NVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)

    Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment1Well-controlled disease observed as fast as two weeks, with demonstrated safety profile that requires no lab monitoring11.7 million people in US live with CSU; more than half remain symptomatic despite increasing doses of antihistamines2,3Remibrutinib also in clinical development for chronic inducible urticaria, food allergy, and hidradenitis suppurativa, expanding Novartis Immunology portfolioEAST HANOVER, N.J., Sept. 30, 2025 /PRNewswire/ -- Novartis announced today that Rhapsido® (remibrutinib) received US Food and Drug Administration (FDA) approval as a

    9/30/25 5:23:00 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NYSE Content Advisory: Pre-Market Update + Snowflake celebrates 2025 Startup Challenge

    NEW YORK, Sept. 30, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on September 30th Stocks are fractionally lower Tuesday morning following a winning start to the week. The major averages are on pace to end September and Q3 in the green. The S&P 500 is up more than 7% over the past three months.Investors will be monitoring the latest developments in Washington as a potential government shutdown looms. If congress doesn't reach a funding deal by tonigh

    9/30/25 8:55:00 AM ET
    $ICE
    $OTF
    $SNOW
    Investment Bankers/Brokers/Service
    Finance
    Computer Software: Prepackaged Software
    Technology

    ICE's Total Futures Markets at Record Open Interest With Record Commodity and Energy Futures Open Interest

    Record Open Interest across Natural Gas, Oil, TTF and Brent Futures Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, and home to the largest and most liquid energy markets in the world, today announced record open interest (OI) across its total futures markets of 56.8 million on September 25, 2025, with record OI of 43 million commodity futures and record OI of 41 million energy futures. ICE's oil futures markets reached record OI of 11 million on September 26, 2025, up 20% year-over-year (y/y) with ICE Brent futures hitting record OI of 3 million on September 24, 2025, up 30% y/y. Brent is the price barometer for three quarters of internatio

    9/30/25 8:00:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $AII
    $ICE
    $NVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hill Jonathan Hopkin was granted 1,381 shares, increasing direct ownership by 2,466% to 1,437 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    9/24/25 5:00:03 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    New insider Hill Jonathan Hopkin claimed ownership of 56 shares (SEC Form 3)

    3 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    9/24/25 4:30:04 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Chief Operating Officer Williams Stuart Glen sold $161,542 worth of shares (939 units at $172.04), decreasing direct ownership by 5% to 16,624 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    9/19/25 4:30:08 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $AII
    $ICE
    $NVS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 1, 2024 - FDA Roundup: November 1, 2024

    For Immediate Release: November 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub,” by Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER) and Peter Marks, M.D., Ph.D., director

    11/1/24 3:18:19 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AII
    $ICE
    $NVS
    Leadership Updates

    Live Leadership Updates

    View All

    Lord Hill of Oareford Elected to Board of Directors of Intercontinental Exchange

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its Board of Directors has elected The Rt. Hon. the Lord Hill of Oareford CBE (Lord Hill) as a new director, effective September 18, 2025. Lord Hill, who currently serves on the Board of Directors of ICE Endex Markets, a subsidiary of ICE, is also expected to join the Board of Directors of ICE Futures Europe subject to regulatory approval. "On behalf of the Board, I am pleased to welcome our colleague, Lord Hill, to his expanded role at ICE," said Jeffrey C. Sprecher, Founder, Chair and CEO of Intercontinental Exchange. "Lord Hill brings tremendous depth and breadth of experi

    9/18/25 4:15:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 22nd Markets are closely watching the Fed's economic policy symposium in Jackson Hole, where Chair Jerome Powell will speak at 10 a.m. ET.Nearly 70% of traders expect a Fed rate cut in September amid dual concerns about inflation and employment highlighted in the Fed's July meeting minutes.The Fed's July meeting minutes emphasized policymakers' concerns about both inflation ris

    8/22/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Mizuho Americas Joins ICE Clear Credit as Clearing Member

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that Mizuho Americas through its security-based swap dealer Mizuho Capital Markets LLC, part of Mizuho Financial Group (NYSE:MFG), has become a clearing member at ICE Clear Credit, the leading global clearinghouse for credit default swaps. "Mizuho Americas is excited to join ICE Clear Credit to enhance our product offering and approach to capital and risk management delivering efficiencies across our CDS portfolios," said Natalya Rasmussen, Chief Operating Officer, Fixed Income Division, Mizuho Americas. "The opportunity to centrally clear products is an important step forward for

    8/6/25 9:00:00 AM ET
    $ICE
    $MFG
    Investment Bankers/Brokers/Service
    Finance
    Major Banks

    $AII
    $ICE
    $NVS
    Financials

    Live finance-specific insights

    View All

    NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

    NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 27th Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon.As the most heavily weighted company in the S&P 500 at more than 8%, Nvidia's results will likely be felt by investors throughout the rest of the week and provide insight into the level of demand for AI.The

    8/27/25 8:55:00 AM ET
    $ABT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange Approves Third Quarter Dividend of $0.48 per Share

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, announced today a $0.48 per share dividend for the third quarter of 2025, which is up 7% from the $0.45 per share dividend paid in the third quarter of 2024. The cash dividend is payable on September 30, 2025 to stockholders of record as of September 16, 2025. The ex-dividend date is September 16, 2025. About Intercontinental Exchange Intercontinental Exchange, Inc. (NYSE:ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-

    7/31/25 7:35:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange Reports Strong Second Quarter 2025

    Intercontinental Exchange (NYSE:ICE):  Record 2Q25 net revenues of $2.5 billion, +10% y/y                 2Q25 GAAP diluted earnings per share (EPS) of $1.48, +35% y/y                 2Q25 adj. diluted EPS of $1.81, +19% y/y                 Record 2Q25 operating income of $1.3 billion, +22% y/y; record adj. operating income of $1.6 billion, +14% y/y                 2Q25 operating margin of 51%; adj. operating margin of 61%                 Through June 30, 2025, returned over $1 billion to stockholders, including $496 million in share repurchases     Jeffrey C. Sprecher, ICE Chair & Chief Executive Officer, said, "We are p

    7/31/25 7:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $AII
    $ICE
    $NVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Novartis AG

    SC 13D/A - NOVARTIS AG (0001114448) (Filed by)

    10/17/24 4:01:28 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Intercontinental Exchange Inc. (Amendment)

    SC 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    2/13/24 1:23:13 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Intercontinental Exchange Inc. (Amendment)

    SC 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    2/3/23 9:43:08 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance